Studying vertebrate topoisomerase 2 function using a conditional knockdown system in DT40 cells

Nucleic Acids Research

Volumn 37, Issue 14, 2009, Pages

  Johnson, Mark ^a,b   Phua, Hui Hui ^a,c   Bennett, Sophia C ^a,d   Spence, Jennifer M ^a,e   Farr, Christine J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); MESSENGER RNA; SHORT HAIRPIN RNA; TETRACYCLINE; ISOENZYME;

ANEUPLOIDY; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; DT40 CELL STRAIN; ENZYME ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IN SITU HYBRIDIZATION; LYMPHOCYTE DEPLETION; NONHUMAN; PHENOTYPE; POLYPLOIDY; PRIORITY JOURNAL; RNA INTERFERENCE; TRANSGENE; VERTEBRATE; ANIMAL; CHICKEN; DRUG ANTAGONISM; GENE SILENCING; GENETICS; LETHAL GENE; MITOSIS INDEX; PLOIDY; TUMOR CELL LINE;

AVES; VERTEBRATA;

ANIMALS; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHICKENS; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; GENE KNOCKDOWN TECHNIQUES; GENES, LETHAL; ISOENZYMES; MITOTIC INDEX; PHENOTYPE; PLOIDIES; RNA INTERFERENCE; TRANSGENES;

EID: 69049108814     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp480     Document Type: Article

References (57)

1. Buerstedde,J.-M. and Takeda,S. (2006) Reviews and protocols in DT40 research. Subcell. Biochem., 40, 1-477.
2. Hudson,D.F., Morrison,C., Ruchaud,S. and Earnshaw,W.C. (2002) Reverse genetics of essential genes in tissue-culture cells: 'dead cells talking'. Trends Cell Biol., 12, 281-287.
3. Martin,S.E. and Caplen,N.J. (2007) Applications of RNA interference in mammalian systems. Annu. Rev. Genomics Hum. Genet., 8, 81-108.
4. Chung,T.D., Drake,F.H., Tan,K.B., Per,S.R., Crooke,S.T. and Mirabelli,C.K. (1989) Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc. Natl Acad. Sci. USA, 86, 9431-9435.
5. Niimi,A., Suka,N., Harata,M., Kikuchi,A. and Mizuno,S. (2001) Co-localization of chicken DNA topoisomerase IIalpha, but not beta, with sites of DNA replication and possible involvement of a C-terminal region of alpha through its binding to PCNA. Chromosoma, 110, 102-114.
6. Akimitsu,N., Adachi,N., Hirai,H., Hossain,M.S., Hamamoto,H., Kobayashi,M., Aratani,Y., Koyama,H. and Sekimizu,K. (2003) Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIalpha. Genes Cells, 8, 393-402.
7. Chaly,N., Chen,X., Dentry,J. and Brown,D.L. (1996) Organization of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells. Chromosome Res., 4, 457-466.
8. Christensen,M.O., Larsen,M.K., Barthelmes,H.U., Hock,R., Andersen,C.L., Kjeldsen,E., Knudsen,B.R., Westergaard,O., Boege,F. and Mielke,C. (2002) Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells. J. Cell Biol., 157, 31-44.
9. Grue,P., Grasser,A., Sehested,M., Jensen,P.B., Uhse,A., Straub,T., Ness,W. and Boege,F. (1998) Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cells. J. Biol. Chem., 273, 33660-33666.
10. Heck,M.M., Hittelman,W.N. and Earnshaw,W.C. (1988) Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc. Natl Acad. Sci. USA, 85, 1086-1090.
11. Meyer,K.N., Kjeldsen,E., Straub,T., Knudsen,B.R., Hickson,I.D., Kikuchi,A., Kreipe,H. and Boege,F. (1997) Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol., 136, 775-788.
12. Null,A.P., Hudson,J. and Gorbsky,G.J. (2002) Both alpha and beta isoforms of mammalian DNA topoisomerase II associate with chromosomes in mitosis. Cell Growth Differ., 13, 325-333.
13. Woessner,R.D., Mattern,M.R., Mirabelli,C.K., Johnson,R.K. and Drake,F.H. (1991) Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ., 2, 209-214.
14. Yang,X., Li,W., Prescott,E.D., Burden,S.J. and Wang,J.C. (2000) DNA topoisomerase IIbeta and neural development. Science, 287, 131-134.
15. Linka,R.M., Porter,A.C., Volkov,A., Mielke,C., Boege,F. and Christensen,M.O. (2007) C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo. Nucleic Acids Res., 35, 3810-3822.
16. Porter,A.C. and Farr,C.J. (2004) Topoisomerase II: Untangling its contribution at the centromere. Chromosome Res., 12, 569-583.
17. Wang,J.C. (2002) Cellular roles of DNA topoisomerases: A molecular perspective. Nat. Rev. Mol. Cell Biol., 3, 430-440.
18. Carpenter,A.J. and Porter,A.C. (2004) Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line. Mol. Biol. Cell, 15, 5700-5711.
19. Paddison,P.J., Caudy,A.A., Sachidanandam,R. and Hannon,G.J. (2004) Short hairpin activated gene silencing in mammalian cells. Methods Mol. Biol., 265, 85-100.
20. Toyoda,E., Kagaya,S., Cowell,I.G., Kurosawa,A., Kamoshita,K., Nishikawa,K., Iiizumi,S., Koyama,H., Austin,C.A. and Adachi,N. (2008) NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform. J. Biol. Chem., 283, 23711-23720.
21. Sakaguchi,A. and Kikuchi,A. (2004) Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. J. Cell Sci., 117, 1047-1054.
22. Toyoda,Y. and Yanagida,M. (2006) Coordinated requirements of human topo II and cohesin for metaphase centromere alignment under Mad2-dependent spindle checkpoint surveillance. Mol. Biol. Cell, 17, 2287-2302.
23. Deming,P.B., Cistulli,C.A., Zhao,H., Graves,P.R., Piwnica- Worms,H., Paules,R.S., Downes,C.S. and Kaufmann,W.K. (2001) The human decatenation checkpoint. Proc. Natl Acad. Sci. USA, 98, 12044-12049.
24. Downes,C.S., Clarke,D.J., Mullinger,A.M., Gimenez-Abian,J.F., Creighton,A.M. and Johnson,R.T. (1994) A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature, 372, 467-470.
25. Damelin,M., Sun,Y.E., Sodja,V.B. and Bestor,T.H. (2005) Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell, 8, 479-484.
26. Kaufmann,W.K. (2006) Dangerous entanglements. Trends Mol. Med., 12, 235-237.
27. Sauer,B. and Henderson,N. (1990) Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol., 2 441-449.
28. Petruti-Mot,A.S. and Earnshaw,W.C. (2000) Two differentially spliced forms of topoisomerase IIalpha and beta mRNAs are conserved between birds and humans. Gene, 258, 183-192.
29. Bell,A.C., West,A.G. and Felsenfeld,G. (1999) The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell, 98, 387-396.
30. Arakawa,H. and Buerstedde,J.M. (2006) DT40 gene disruptions: A how-to for the design and the construction of targeting vectors. Subcell. Biochem., 40, 1-9.
31. Eguchi,A., Kondoh,T., Kosaka,H., Suzuki,T., Momota,H., Masago,A., Yoshida,T., Taira,H., Ishii-Watabe,A., Okabe,J. et al. (2000) Identification and characterization of cell lines with a defect in a post-adsorption stage of Sendai virus-mediated membrane fusion. J. Biol. Chem., 275, 17549-17555.
32. Pfaffl,M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
33. Gillespie,D.A. and Walker,M. (2006) Mitotic index determination by flow cytometry. Subcell. Biochem., 40, 355-358.
34. Franklin,R. and Sale,J.E. (2006) 2D cell cycle analysis. Subcell. Biochem., 40, 405-408.
35. Szuts,D. and Sale,J.E. (2006) Subnuclear immunofluorescence. Subcell. Biochem., 40, 395-398.
36. Yao,F., Svensjo,T., Winkler,T., Lu,M., Eriksson,C. and Eriksson,E. (1998) Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum. Gene Ther., 9, 1939-1950.
37. Bell,A.C., West,A.G. and Felsenfeld,G. (2001) Insulators and boundaries: versatile regulatory elements in the eukaryotic. Science, 291 447-450.
38. Chung,J.H., Whiteley,M. and Felsenfeld,G. (1993) A 50 element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell, 74, 505-514.
39. Pikaart,M.J., Recillas-Targa,F. and Felsenfeld,G. (1998) Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev., 12, 2852-2862.
40. Spence,J.M., Phua,H.H., Mills,W., Carpenter,A.J., Porter,A.C. and Farr,C.J. (2007) Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads. J. Cell Sci., 120, 3952-3964.
41. Andoh,T. and Ishida,R. (1998) Catalytic inhibitors of DNA topoisomerase II. Biochim. Biophys. Acta, 1400, 155-171.
42. Grauslund,M., Thougaard,A.V., Fuchtbauer,A., Hofland,K.F., Hjorth,P.H., Jensen,P.B., Sehested,M., Fuchtbauer,E.M. and Jensen,L.H. (2007) A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo. Mol. Pharmacol., 72, 1003-1014.
43. McPherson,J.P. and Goldenberg,G.J. (1998) Induction of apoptosis by deregulated expression of DNA topoisomerase IIalpha. Cancer Res., 58, 4519-4524.
44. Baxter,J. and Diffley,J.F. (2008) Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast. Mol. Cell, 30, 790-802.
45. Classen,S., Olland,S. and Berger,J.M. (2003) Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187. Proc. Natl Acad. Sci. USA, 100 10629-10634.
46. Oestergaard,V.H., Knudsen,B.R. and Andersen,A.H. (2004) Dissecting the cell-killing mechanism of the topoisomerase II-targeting drug ICRF-193. J. Biol. Chem., 279, 28100-28105.
47. Roca,J., Ishida,R., Berger,J.M., Andoh,T. and Wang,J.C. (1994) Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc. Natl Acad. Sci. USA, 91, 1781-1785.
48. Germe,T. and Hyrien,O. (2005) Topoisomerase II-DNA complexes trapped by ICRF-193 perturb chromatin structure. EMBO Rep., 6, 729-735.
49. Hajji,N., Pastor,N., Mateos,S., Dominguez,I. and Cortes,F. (2003) DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193. Mutat. Res., 530, 35-46.
50. Huang,K.C., Gao,H., Yamasaki,E.F., Grabowski,D.R., Liu,S., Shen,L.L., Chan,K.K., Ganapathi,R. and Snapka,R.M. (2001) Topoisomerase II poisoning by ICRF-193. J. Biol. Chem., 276, 44488-44494.
51. Wang,L. and Eastmond,D.A. (2002) Catalytic inhibitors of topoisomerase II are DNA-damaging agents: Induction of chromosomal damage by merbarone and ICRF-187. Environ. Mol. Mutagen., 39, 348-356.
52. Baumann,C., Korner,R., Hofmann,K. and Nigg,E.A. (2007) PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint. Cell, 128, 101-114.
53. Chan,K.L., North,P.S. and Hickson,I.D. (2007) BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J., 26, 3397-3409.
54. Wang,L.H., Schwarzbraun,T., Speicher,M.R. and Nigg,E.A. (2008) Persistence of DNA threads in human anaphase cells suggests late completion of sister chromatid decatenation. Chromosoma, 117 123-135.
55. Banaszynski,L.A., Chen,L.C., Maynard-Smith,L.A., Ooi,A.G. and Wandless,T.J. (2006) A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell, 126, 995-1004.
56. Luo,K., Yuan,J., Chen,J. and Lou,Z. (2008) Topoisomerase IIalpha controls the decatenation checkpoint. Nat. Cell Biol., 11, 204-210.
57. Stucki,M., Clapperton,J.A., Mohammad,D., Yaffe,M.B., Smerdon,S.J. and Jackson,S.P. (2005) MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell, 123, 1213-1226.